Andrzej Jakubowiak to Risk Factors
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Risk Factors.
Connection Strength
0.070
-
Introduction: recent advances in the understanding and management of multiple myeloma. Semin Oncol. 2013 Oct; 40(5):535-6.
Score: 0.054
-
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma. Blood. 2016 09 01; 128(9):1174-80.
Score: 0.016